Leukocytosis in patients with favism and association with blood transfusion
Introduction Leukocytosis is a condition marked by abnormal increase in leukocyte count due to an inflammatory response as a defense against most of the infections, or bone tumors; including leukemia. The aim of this study is to analyze the effect of blood transfusion in leukocytosis patients with f...
Gespeichert in:
| Veröffentlicht in: | Journal of clinical laboratory analysis 2019-07, Vol.33 (6), p.e22906-n/a |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | n/a |
|---|---|
| container_issue | 6 |
| container_start_page | e22906 |
| container_title | Journal of clinical laboratory analysis |
| container_volume | 33 |
| creator | Faraji‐Goodarzi, Mojgan Taee, Nadereh Bajelan, Amir Safdari, Mohammad |
| description | Introduction
Leukocytosis is a condition marked by abnormal increase in leukocyte count due to an inflammatory response as a defense against most of the infections, or bone tumors; including leukemia. The aim of this study is to analyze the effect of blood transfusion in leukocytosis patients with favism as compared to patients treated with antibiotics or combination of both.
Methods
A total of 97 patients with favism who were referred to the University hospital in 2016‐2017 were studied.
Key findings
These patients experienced acute hemolysis following beans meal. These patients were either treated with blood transfusion, antibiotics or combination of both.
Conclusions
This study shows that blood transfusion is an effective therapeutic option for the treatment of leukocytosis. Antibiotics are not deemed necessary for the treatment and blood transfusion alone, can decrease leukocytes to the normal level. |
| doi_str_mv | 10.1002/jcla.22906 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6642307</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2260269674</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4486-dfb43c86984964f0f0f11d50794915f46230320c1c113525e834722c492271583</originalsourceid><addsrcrecordid>eNp9kM1LwzAchoMobk4v_gFS8CZ0_vLRNLkIY_g98KLnkKWty-ya2bQb--_N7Bx6kRwCeR-evLwInWMYYgByPTelHhIigR-gPgYpYiJIcoj6IEQaC8C0h068nwOAkJgfox7FkDJIaR89T_L2w5lN47z1ka2ipW5sXjU-WttmFhV6Zf0i0lUWae-dsSF1VZdNS-eyqKl15YvWh-dTdFTo0udnu3uA3u5uX8cP8eTl_nE8msSGMcHjrJgyagSXgknOCggH4yyBVDKJk4JxQoESMNhgTBOS5IKylBDDJCEpTgQdoJvOu2ynizwzoW6tS7Ws7ULXG-W0VX-Tys7Uu1spzllwp0FwuRPU7rPNfaPmrq2r0FkRwoFwyVMWqKuOMrXzvs6L_Q8Y1HZ4tR1efQ8f4Ivfnfboz9IBwB2wtmW--UelnsaTUSf9At2GjWg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2260269674</pqid></control><display><type>article</type><title>Leukocytosis in patients with favism and association with blood transfusion</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Wiley-Blackwell Open Access Titles</source><source>PubMed Central</source><creator>Faraji‐Goodarzi, Mojgan ; Taee, Nadereh ; Bajelan, Amir ; Safdari, Mohammad</creator><creatorcontrib>Faraji‐Goodarzi, Mojgan ; Taee, Nadereh ; Bajelan, Amir ; Safdari, Mohammad</creatorcontrib><description>Introduction
Leukocytosis is a condition marked by abnormal increase in leukocyte count due to an inflammatory response as a defense against most of the infections, or bone tumors; including leukemia. The aim of this study is to analyze the effect of blood transfusion in leukocytosis patients with favism as compared to patients treated with antibiotics or combination of both.
Methods
A total of 97 patients with favism who were referred to the University hospital in 2016‐2017 were studied.
Key findings
These patients experienced acute hemolysis following beans meal. These patients were either treated with blood transfusion, antibiotics or combination of both.
Conclusions
This study shows that blood transfusion is an effective therapeutic option for the treatment of leukocytosis. Antibiotics are not deemed necessary for the treatment and blood transfusion alone, can decrease leukocytes to the normal level.</description><identifier>ISSN: 0887-8013</identifier><identifier>EISSN: 1098-2825</identifier><identifier>DOI: 10.1002/jcla.22906</identifier><identifier>PMID: 31074073</identifier><language>eng</language><publisher>United States: John Wiley & Sons, Inc</publisher><subject>Anti-Bacterial Agents - therapeutic use ; Antibiotics ; Beans ; Blood Transfusion ; Blood transfusions ; Bone tumors ; Brief Report ; favism ; Favism - therapy ; Female ; Humans ; Inflammation ; Leukocyte Count ; Leukocytes ; Leukocytosis ; Leukocytosis - therapy ; Male ; Patients ; Treatment Outcome</subject><ispartof>Journal of clinical laboratory analysis, 2019-07, Vol.33 (6), p.e22906-n/a</ispartof><rights>2019 The Authors. Published by Wiley Periodicals, Inc.</rights><rights>2019 The Authors. Journal of Clinical Laboratory Analysis Published by Wiley Periodicals, Inc.</rights><rights>2019. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4486-dfb43c86984964f0f0f11d50794915f46230320c1c113525e834722c492271583</citedby><cites>FETCH-LOGICAL-c4486-dfb43c86984964f0f0f11d50794915f46230320c1c113525e834722c492271583</cites><orcidid>0000-0002-6046-6342 ; 0000-0002-7494-2557</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642307/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642307/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,1411,11542,27903,27904,45553,45554,46030,46454,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31074073$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Faraji‐Goodarzi, Mojgan</creatorcontrib><creatorcontrib>Taee, Nadereh</creatorcontrib><creatorcontrib>Bajelan, Amir</creatorcontrib><creatorcontrib>Safdari, Mohammad</creatorcontrib><title>Leukocytosis in patients with favism and association with blood transfusion</title><title>Journal of clinical laboratory analysis</title><addtitle>J Clin Lab Anal</addtitle><description>Introduction
Leukocytosis is a condition marked by abnormal increase in leukocyte count due to an inflammatory response as a defense against most of the infections, or bone tumors; including leukemia. The aim of this study is to analyze the effect of blood transfusion in leukocytosis patients with favism as compared to patients treated with antibiotics or combination of both.
Methods
A total of 97 patients with favism who were referred to the University hospital in 2016‐2017 were studied.
Key findings
These patients experienced acute hemolysis following beans meal. These patients were either treated with blood transfusion, antibiotics or combination of both.
Conclusions
This study shows that blood transfusion is an effective therapeutic option for the treatment of leukocytosis. Antibiotics are not deemed necessary for the treatment and blood transfusion alone, can decrease leukocytes to the normal level.</description><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Antibiotics</subject><subject>Beans</subject><subject>Blood Transfusion</subject><subject>Blood transfusions</subject><subject>Bone tumors</subject><subject>Brief Report</subject><subject>favism</subject><subject>Favism - therapy</subject><subject>Female</subject><subject>Humans</subject><subject>Inflammation</subject><subject>Leukocyte Count</subject><subject>Leukocytes</subject><subject>Leukocytosis</subject><subject>Leukocytosis - therapy</subject><subject>Male</subject><subject>Patients</subject><subject>Treatment Outcome</subject><issn>0887-8013</issn><issn>1098-2825</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>WIN</sourceid><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp9kM1LwzAchoMobk4v_gFS8CZ0_vLRNLkIY_g98KLnkKWty-ya2bQb--_N7Bx6kRwCeR-evLwInWMYYgByPTelHhIigR-gPgYpYiJIcoj6IEQaC8C0h068nwOAkJgfox7FkDJIaR89T_L2w5lN47z1ka2ipW5sXjU-WttmFhV6Zf0i0lUWae-dsSF1VZdNS-eyqKl15YvWh-dTdFTo0udnu3uA3u5uX8cP8eTl_nE8msSGMcHjrJgyagSXgknOCggH4yyBVDKJk4JxQoESMNhgTBOS5IKylBDDJCEpTgQdoJvOu2ynizwzoW6tS7Ws7ULXG-W0VX-Tys7Uu1spzllwp0FwuRPU7rPNfaPmrq2r0FkRwoFwyVMWqKuOMrXzvs6L_Q8Y1HZ4tR1efQ8f4Ivfnfboz9IBwB2wtmW--UelnsaTUSf9At2GjWg</recordid><startdate>201907</startdate><enddate>201907</enddate><creator>Faraji‐Goodarzi, Mojgan</creator><creator>Taee, Nadereh</creator><creator>Bajelan, Amir</creator><creator>Safdari, Mohammad</creator><general>John Wiley & Sons, Inc</general><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>WIN</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-6046-6342</orcidid><orcidid>https://orcid.org/0000-0002-7494-2557</orcidid></search><sort><creationdate>201907</creationdate><title>Leukocytosis in patients with favism and association with blood transfusion</title><author>Faraji‐Goodarzi, Mojgan ; Taee, Nadereh ; Bajelan, Amir ; Safdari, Mohammad</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4486-dfb43c86984964f0f0f11d50794915f46230320c1c113525e834722c492271583</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Antibiotics</topic><topic>Beans</topic><topic>Blood Transfusion</topic><topic>Blood transfusions</topic><topic>Bone tumors</topic><topic>Brief Report</topic><topic>favism</topic><topic>Favism - therapy</topic><topic>Female</topic><topic>Humans</topic><topic>Inflammation</topic><topic>Leukocyte Count</topic><topic>Leukocytes</topic><topic>Leukocytosis</topic><topic>Leukocytosis - therapy</topic><topic>Male</topic><topic>Patients</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Faraji‐Goodarzi, Mojgan</creatorcontrib><creatorcontrib>Taee, Nadereh</creatorcontrib><creatorcontrib>Bajelan, Amir</creatorcontrib><creatorcontrib>Safdari, Mohammad</creatorcontrib><collection>Wiley-Blackwell Open Access Titles</collection><collection>Wiley Free Content</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of clinical laboratory analysis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Faraji‐Goodarzi, Mojgan</au><au>Taee, Nadereh</au><au>Bajelan, Amir</au><au>Safdari, Mohammad</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Leukocytosis in patients with favism and association with blood transfusion</atitle><jtitle>Journal of clinical laboratory analysis</jtitle><addtitle>J Clin Lab Anal</addtitle><date>2019-07</date><risdate>2019</risdate><volume>33</volume><issue>6</issue><spage>e22906</spage><epage>n/a</epage><pages>e22906-n/a</pages><issn>0887-8013</issn><eissn>1098-2825</eissn><abstract>Introduction
Leukocytosis is a condition marked by abnormal increase in leukocyte count due to an inflammatory response as a defense against most of the infections, or bone tumors; including leukemia. The aim of this study is to analyze the effect of blood transfusion in leukocytosis patients with favism as compared to patients treated with antibiotics or combination of both.
Methods
A total of 97 patients with favism who were referred to the University hospital in 2016‐2017 were studied.
Key findings
These patients experienced acute hemolysis following beans meal. These patients were either treated with blood transfusion, antibiotics or combination of both.
Conclusions
This study shows that blood transfusion is an effective therapeutic option for the treatment of leukocytosis. Antibiotics are not deemed necessary for the treatment and blood transfusion alone, can decrease leukocytes to the normal level.</abstract><cop>United States</cop><pub>John Wiley & Sons, Inc</pub><pmid>31074073</pmid><doi>10.1002/jcla.22906</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0002-6046-6342</orcidid><orcidid>https://orcid.org/0000-0002-7494-2557</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0887-8013 |
| ispartof | Journal of clinical laboratory analysis, 2019-07, Vol.33 (6), p.e22906-n/a |
| issn | 0887-8013 1098-2825 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6642307 |
| source | MEDLINE; DOAJ Directory of Open Access Journals; Wiley Online Library Journals Frontfile Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Wiley-Blackwell Open Access Titles; PubMed Central |
| subjects | Anti-Bacterial Agents - therapeutic use Antibiotics Beans Blood Transfusion Blood transfusions Bone tumors Brief Report favism Favism - therapy Female Humans Inflammation Leukocyte Count Leukocytes Leukocytosis Leukocytosis - therapy Male Patients Treatment Outcome |
| title | Leukocytosis in patients with favism and association with blood transfusion |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T18%3A39%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Leukocytosis%20in%20patients%20with%20favism%20and%20association%20with%20blood%20transfusion&rft.jtitle=Journal%20of%20clinical%20laboratory%20analysis&rft.au=Faraji%E2%80%90Goodarzi,%20Mojgan&rft.date=2019-07&rft.volume=33&rft.issue=6&rft.spage=e22906&rft.epage=n/a&rft.pages=e22906-n/a&rft.issn=0887-8013&rft.eissn=1098-2825&rft_id=info:doi/10.1002/jcla.22906&rft_dat=%3Cproquest_pubme%3E2260269674%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2260269674&rft_id=info:pmid/31074073&rfr_iscdi=true |